Skip to main content
. 2020 Aug 20;56(9):423. doi: 10.3390/medicina56090423

Table 4.

List of the most commercialized liposome formulations.

Commercialized Liposomes Formulation Commercial Name Author (Year)
PEGylated liposomal doxorubicin (Doxil/Caelyx) Gabizon et al. (2003) [34]
Non-PEGylated liposomal doxorubicin (Myocet) Rivankar (2014) [35]
Liposomal daunorubicin (DaunoXome) Petre, Dittmer (2007) [36]
Liposomal cytarabine (DepoCyt) Bomgaars et al. (2004) [37]